rtki cpd and Leiomyoma

rtki cpd has been researched along with Leiomyoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ben-Bassat, H; Hartzstark, Z; Klein, BY; Laufer, N; Levitzki, R; Rojansky, N; Shlomai, Z; Shushan, A	1

Other Studies

1 other study(ies) available for rtki cpd and Leiomyoma

Article	Year
The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth. Human reproduction (Oxford, England), 2004, Volume: 19, Issue:9 Topics: Adult; Apoptosis; Cell Cycle; Cell Division; Cells, Cultured; Enzyme Inhibitors; ErbB Receptors; Estradiol; Female; Humans; Leiomyoma; Myometrium; Phosphorylation; Progesterone; Protein-Tyrosine Kinases; Quinazolines; Tyrphostins; Uterine Neoplasms	2004

Article

Year

The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth.

Human reproduction (Oxford, England), 2004, Volume: 19, Issue:9

Topics: Adult; Apoptosis; Cell Cycle; Cell Division; Cells, Cultured; Enzyme Inhibitors; ErbB Receptors; Estradiol; Female; Humans; Leiomyoma; Myometrium; Phosphorylation; Progesterone; Protein-Tyrosine Kinases; Quinazolines; Tyrphostins; Uterine Neoplasms

2004